TY  - BOOK
AU  - Miele,Lucio
AU  - Artavanis-Tsakonas,Spyros
ED  - SpringerLink (Online service)
TI  - Targeting Notch in Cancer: From the Fruit Fly to the Clinic 
SN  - 9781493988594
AV  - RC261-271 
U1  - 614.5999 23
PY  - 2018///
CY  - New York, NY
PB  - Springer New York, Imprint: Springer
KW  - Cancer research
KW  - Pharmacology
KW  - Cancer Research
KW  - Pharmacology/Toxicology
N1  - Acceso multiusuario; Structural Biology of Notch Signaling -- Non-Canonical Notch Signaling -- Dual Function of Notch Signaling in Cancer - Oncogene and Tumorsuppressor -- Out on the Fringe: Modulation of Notch Signaling by Glycosylation -- Notch signaling: A pivot regulator of adaptive and innate immunity -- Notch in Ovarian Cancer -- Notch Signaling in Graft-versus-Host Disease  -- Notch Signaling in T-Cell Acute Lymphoblastic Leukemia and Other Hematologic Malignancies -- The Role of Notch in Breast Cancer -- Notch in Lung Cancer -- Notch Signaling in Pediatric Soft tissue Sarcoma -- Notch Ligands in Hematopoietic Stem Cell production -- Notch Signaling in the normal intestine and intestinal Cancer -- Notch Signaling in Estrogen-Dependent Cancers -- Index
N2  - The serendipitously discovered link between developmental biology and cancer, touched of an explosion of discoveries on the role of Notch in human malignancies, including every aspect of cancer biology, from control of differentiation, proliferation and apoptosis in transformed cells to angiogenesis, tumor-stroma interaction and anti-cancer immune responses. A number of observations have revealed that Notch even plays a role in the renewal of cancer stem cells and tumor initiating cells, which are thought to be a major cause of resistance to treatment. Targeting Notch in Cancer will provide researchers, oncologists, pharmacologists and students with a detailed understanding of the intricate cross-talk between Notch and other pathways of therapeutic interest so to better design rational drug combinations for specific diseases and disease subsets. Divided into two parts, Part I describes in detail what we know about the genetics, molecular biology, biochemistry and structural biology of Notch, as well as the role of Notch in such processes as angiogenesis and immune surveillance. Without insights gained from these basic studies, rational targeting of Notch in human disease would be impossible. Part II describes the role of Notch and ongoing experimental therapeutic efforts in the most important subtypes of human cancers, organized in a clinically oriented fashion by organs and systems affected
UR  - http://148.231.10.114:2048/login?url=https://doi.org/10.1007/978-1-4939-8859-4
ER  -